PAG
BMY icon

Private Advisor Group’s Bristol-Myers Squibb BMY Stock Holding History

Private Advisor Group’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-600
Closed -$1K – 1271
2014
Q2 		$1K Buy
+600
New +$29.6K ﹤0.01% 928

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Private Advisor Group's BMY Position: Q1 2026 in Review

Private Advisor Group reduced its Bristol-Myers Squibb (BMY) stake by 0.3% in Q1 2026, selling an estimated $47.8K and leaving 268,500 shares worth $16.3M. The position accounts for 0.08% of the portfolio, ranked #276.

Private Advisor Group first reported a position in BMY in Q4 2013 and has held it in 50 quarters since. The position peaked at $31.9M in Q3 2021. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Private Advisor Group held 268,500 shares of Bristol-Myers Squibb worth $16.3M as of Q1 2026.
  • Private Advisor Group sold 820 Bristol-Myers Squibb shares in Q1 2026, an estimated $47.8K.
  • Bristol-Myers Squibb made up 0.08% of Private Advisor Group's portfolio in Q1 2026, its #276 holding.
  • Private Advisor Group first reported a position in Bristol-Myers Squibb in Q4 2013 and has held it in 50 quarters since.
  • Private Advisor Group's Bristol-Myers Squibb position peaked at $31.9M in Q3 2021.
  • 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Private Advisor Group's 13F filing for Q1 2026, filed 27 Apr 2026.